←
CellSig_Lab312 posts
CellSig_Lab avatar

CellSig_Lab

@CellsigL

CellSig is led by Bart Vanhaesebroeck. We aim to improve understanding & drug targeting of the PI3K/PTEN pathway in cancer & beyond. #PI3Kδ #PI3Kactivators

◷ Joined October 2019▧ 74 Photos and videos
CellSig_Lab avatar
CellSig_Lab@CellsigL·20 May 2024

Dear Klaus – thank you very much for your very kind message: you & your CellSig Colleagues made these PI3K discoveries possible, and continue to do so - we now only need more approved PI3K drugs, inhibitors or activators😊. Keep up the good work !

This tweet is unavailable

Cancer Grand Challenges avatar
⟳ CellSig_Lab retweeted
Cancer Grand Challenges@CancerGrand·Oct 27

What drives someone to take on one of cancer research's toughest challenges? In our latest Stories Behind the Science interview, Bart Vanhaesebroeck shares his motivation behind leading team REWIRE-CAN and why he believes it's time to think differently about killing cancer cells. Read the full Q&A: bit.ly/3V5Suc2 📹 Includes footage from @ucl

0:37
CellSig_Lab avatar
CellSig_Lab@CellsigL·22 Jul 2025

Congratulations to Sara Al-Jarrah Setó (‘Sarita’- in white T-shirt in front of picture) for successfully defending her PhD thesis in the @Cellsig Lab at @uclcancer, funded by PIPgen MSCA-ITN EU - pipgen.eu/ Wishing everyone a joyful and relaxing summer !!

Post attachment
Biochemical Journal avatar
⟳ CellSig_Lab retweeted
Biochemical Journal@Biochem_Journal·4 Jul 2025

Are you interested in the underlying molecular mechanisms of life? Explore the latest completed issue of the Biochemical Journal which delves into the newest developments in this exciting area! ow.ly/3JiA50Wi4Qc

Post attachment
Neil Vasan avatar
⟳ CellSig_Lab retweeted
Neil Vasan@NeilVasan·28 Jan 2025

Inavo improves OS - great news for patients. This is the first PI3Ki to improve OS in ER+ MBC. The future is triplets imo - eventually we will have firstline CDK4/6i + PI3K/AKTi + AI. @PIK3CApathbreak @mbcalliance roche.com/media/releases/med…

Biochemical Journal avatar
⟳ CellSig_Lab retweeted
Biochemical Journal@Biochem_Journal·8 Jan 2025

Interested in submitting your work to an independent society publisher? Our journals cover the breadth of the molecular biosciences. With open access options available, take a look at our journals and find the home for your work: ow.ly/HhES50UwuUg

Post attachment
Josep Carreras Leukaemia Research Institute (IJC) avatar
⟳ CellSig_Lab retweeted
Josep Carreras Leukaemia Research Institute (IJC)@CarrerasIJC·3 Dec 2024

“Queremos estudiar en varios contextos patológicos los diferentes comportamientos que tienen las células endoteliales de un mismo vaso, lo que permitirá avanzar en el conocimiento de muchas enfermedades vinculadas a los vasos sanguíneos”. La Dra. @MarionaGraupera explica en #BigVang de @LaVanguardia 🗞️ el proyecto #BEMOSAIC. No te pierdas la entrevista ⬇️ lavanguardia.com/ciencia/202…

Post attachment
Biochemical Journal avatar
⟳ CellSig_Lab retweeted
Biochemical Journal@Biochem_Journal·16 Nov 2024

With over 1.1M article views in 2023, Biochemical Journal has been at the forefront of exploring the mechanisms of life for over 100 years. Find out more about the journal on our website, and consider submitting your high-impact research ow.ly/Gwx950U7UvX

Post attachment